SALT LAKE CITY -– January 22, 2024 – BioUtah, Utah’s trade association dedicated to the life sciences community, in partnership with the University of Utah’s Technology Licensing Office, today announced a venue change and speaker update for the 2024 Entrepreneur and Investor Life Sciences (E&I Summit) sponsored by Wilson Sonsini. The E&I Summit will now be held at the Sheraton Hotel at 150 W 500 S, Salt Lake City, instead of the Radisson Hotel. The date of March 14 remains unchanged, followed by a ski day at Deer Valley Resort on March 15.
Early bird discounts are available until February 23. Register HERE.
Attracting over 400 registrants, the E&I Summit turns the spotlight on Utah’s vibrant innovation ecosystem, convening entrepreneurs, investors (local and national), academic research centers, incubators, service providers and more. As one of the fastest growing life sciences hubs in the nation, Utah’s industry accounts directly and indirectly for $22.6 billion in GDP and approximately 180,000 jobs.
“The E&I Summit is where Utah’s life sciences innovators meet investors and make important connections to support promising new healthcare technologies that can change patient’s lives,” said Kelvyn Cullimore, president and CEO of BioUtah. “We’re proud to be uniquely Utah, remaining true to our long-standing culture of discovery and collaboration.”
Monica DiCenso, managing director and head of Global Investment Opportunities Group at J.P. Morgan Private Bank, will take center stage to shed light on the investment environment and outlook for the life sciences industry. In addition, Dave Perry, executive consultant for Laborie Medical, and former president and CEO of Urotronic, will speak on his startup journey from founding Urotronic to exit in eight years.
A wide range of panels will cover impactful topics, including top-tier CEOs, who will share their well-honed perspectives on building a successful life sciences company.
Principals from national venture capital firms as well as leaders of Utah’s local investment community will discuss what it takes for early-stage companies to attract capital. A dedicated networking session will provide attendees an opportunity to make valuable contacts. The E&I Summit will once again hold its popular Pitch Competition. Nine companies will be selected to present their product before a slate of seasoned judges. Information on all applicant companies will be available on the E&I website.
“The conference is designed to support Utah’s healthcare entrepreneurs and highlight all segments of our industry, from medical devices and diagnostic to drugs and therapeutics,” said Myles Greenberg, CEO of Alucent Biomedical and chair of the BioUtah Board of Directors.
On March 15, following the E&I Summit, attendees can continue their conversations on the slopes during a ski day and luncheon at Deer Valley Resort.
